Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies

Epilepsy Research

Volumn 137, Issue , 2017, Pages 9-18

  Kang, Jing Qiong ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NANTONG UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epilepsy; GABAergic signaling; Ion channels; Mutations; Non ion channels; Vesicles

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; GANAXOLONE; SODIUM CHANNEL NAV1.1; 4 AMINOBUTYRIC ACID RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; DNM1 GENE; DRUG RESISTANT EPILEPSY; EPILEPTOGENESIS; FIRING RATE; FOCAL EPILEPSY; GABAA RECEPTOR GENE; GABAERGIC TRANSMISSION; GENE; GENE IDENTIFICATION; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; HUMAN; MUTANT; NEUROMODULATION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PRRT2 GENE; REVIEW; SCN1A GENE; SIGNAL TRANSDUCTION; SNAP25 GENE; STX1 B GENE; STXBP1 GENE; SYNAPTIC INHIBITION; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; EPILEPSY, GENERALIZED; GABAERGIC NEURONS; GAMMA-AMINOBUTYRIC ACID; HUMANS; RECEPTORS, GABA; SYNAPTIC TRANSMISSION;

EID: 85028398607     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2017.08.013     Document Type: Review

References (109)

1. Alldred, M.J., Mulder-Rosi, J., Lingenfelter, S.E., Chen, G., Luscher, B., Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin. J. Neurosci. 25 (2005), 594–603.
2. Allen, A.S., Berkovic, S.F., Cossette, P., Delanty, N., Dlugos, D., Eichler, E.E., Epstein, M.P., Glauser, T., Goldstein, D.B., Han, Y., Heinzen, E.L., Hitomi, Y., Howell, K.B., Johnson, M.R., Kuzniecky, R., Lowenstein, D.H., Lu, Y.F., Madou, M.R., Marson, A.G., Mefford, H.C., Esmaeeli, N.S., O'Brien, T.J., Ottman, R., Petrovski, S., Poduri, A., Ruzzo, E.K., Scheffer, I.E., Sherr, E.H., Yuskaitis, C.J., Abou-Khalil, B., Alldredge, B.K., Bautista, J.F., Berkovic, S.F., Boro, A., Cascino, G.D., Consalvo, D., Crumrine, P., Devinsky, O., Dlugos, D., Epstein, M.P., Fiol, M., Fountain, N.B., French, J., Friedman, D., Geller, E.B., Glauser, T., Glynn, S., Haut, S.R., Hayward, J., Helmers, S.L., Joshi, S., Kanner, A., Kirsch, H.E., Knowlton, R.C., Kossoff, E.H., Kuperman, R., Kuzniecky, R., Lowenstein, D.H., McGuire, S.M., Motika, P.V., Novotny, E.J., Ottman, R., Paolicchi, J.M., Parent, J.M., Park, K., Poduri, A., Scheffer, I.E., Shellhaas, R.A., Sherr, E.H., Shih, J.J., Singh, R., Sirven, J., Smith, M.C., Sullivan, J., Lin, T.L., Venkat, A., Vining, E.P., Von Allmen, G.K., Weisenberg, J.L., Widdess-Walsh, P., Winawer, M.R., De novo mutations in epileptic encephalopathies. Nature 501 (2013), 217–221.
3. Anderson, E., Berkovic, S., Dulac, O., Gardiner, M., Jain, S., Laue, F.M., Lindhout, D., Noebels, J., Ottman, R., Scaramelli, A., Serratosa, J., Steinlein, O., Avanzini, G., Bailey-Wilson, J., Cardon, L., Fischbach, R., Gwinn-Hardy, K., Leppert, M., Ott, J., Lindblad-Toh, K., Weiss, K., ILAE genetics commission conference report: molecular analysis of complex genetic epilepsies. Epilepsia 43 (2002), 1262–1267.
4. Arain, F.M., Boyd, K.L., Gallagher, M.J., Decreased viability and absence-like epilepsy in mice lacking or deficient in the GABAA receptor alpha1 subunit. Epilepsia 53 (2012), e161–e165.
5. Arain, F., Zhou, C., Ding, L., Zaidi, S., Gallagher, M.J., The developmental evolution of the seizure phenotype and cortical inhibition in mouse models of juvenile myoclonic epilepsy. Neurobiol. Dis. 82 (2015), 164–175.
6. Asinof, S.K., Sukoff Rizzo, S.J., Buckley, A.R., Beyer, B.J., Letts, V.A., Frankel, W.N., Boumil, R.M., Independent neuronal origin of seizures and behavioral comorbidities in an animal model of a severe childhood genetic epileptic encephalopathy. PLoS Genet., 11, 2015, e1005347.
7. Asinof, S., Mahaffey, C., Beyer, B., Frankel, W.N., Boumil, R., Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy. Neurobiol. Dis. 95 (2016), 1–11.
8. Audenaert, D., Schwartz, E., Claeys, K.G., Claes, L., Deprez, L., Suls, A., Van Dyck, T., Lagae, L., Van Broeckhoven, C., Macdonald, R.L., De Jonghe, P., A novel GABRG2 mutation associated with febrile seizures. Neurology 67 (2006), 687–690.
9. Banerjee, P.K., Tillakaratne, N.J., Brailowsky, S., Olsen, R.W., Tobin, A.J., Snead, O.C. III, Alterations in GABAA receptor alpha 1 and alpha 4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats. Exp. Neurol. 154 (1998), 213–223.
10. Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud'homme, J.F., Baulac, M., Brice, A., Bruzzone, R., LeGuern, E., First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat. Genet. 28 (2001), 46–48.
11. Bianchi, M.T., Macdonald, R.L., Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 23 (2003), 10934–10943.
12. Boillot, M., Morin-Brureau, M., Picard, F., Weckhuysen, S., Lambrecq, V., Minetti, C., Striano, P., Zara, F., Iacomino, M., Ishida, S., An-Gourfinkel, I., Daniau, M., Hardies, K., Baulac, M., Dulac, O., LeGuern, E., Nabbout, R., Baulac, S., Novel GABRG2 mutations cause familial febrile seizures. Neurol. Genet., 1, 2015, e35.
13. Boumil, R.M., Letts, V.A., Roberts, M.C., Lenz, C., Mahaffey, C.L., Zhang, Z.W., Moser, T., Frankel, W.N., A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice. PLoS Genet., 6, 2010.
14. Broomall, E., Natale, J.E., Grimason, M., Goldstein, J., Smith, C.M., Chang, C., Kanes, S., Rogawski, M.A., Wainwright, M.S., Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann. Neurol. 76 (2014), 911–915.
15. Carvill, G.L., Weckhuysen, S., McMahon, J.M., Hartmann, C., Moller, R.S., Hjalgrim, H., Cook, J., Geraghty, E., O'Roak, B.J., Petrou, S., Clarke, A., Gill, D., Sadleir, L.G., Muhle, H., von, S.S., Nikanorova, M., Hodgson, B.L., Gazina, E.V., Suls, A., Shendure, J., Dibbens, L.M., De, J.P., Helbig, I., Berkovic, S.F., Scheffer, I.E., Mefford, H.C., GABRA1 and STXBP1: Novel genetic causes of Dravet syndrome. Neurology 82:14 (2014), 1245–1253 Apr 8.
16. Chen, W.J., Lin, Y., Xiong, Z.Q., Wei, W., Ni, W., Tan, G.H., Guo, S.L., He, J., Chen, Y.F., Zhang, Q.J., Li, H.F., Lin, Y., Murong, S.X., Xu, J., Wang, N., Wu, Z.Y., Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat. Genet. 43 (2011), 1252–1255.
17. Cohen, A.S., Lin, D.D., Quirk, G.L., Coulter, D.A., Dentate granule cell GABA(A) receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur. J. Neurosci. 17 (2003), 1607–1616.
18. Cossette, P., Liu, L., Brisebois, K., Dong, H., Lortie, A., Vanasse, M., Saint-Hilaire, J.M., Carmant, L., Verner, A., Lu, W.Y., Wang, Y.T., Rouleau, G.A., Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31 (2002), 184–189.
19. Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J.P., Belzung, C., Fritschy, J.M., Luscher, B., Mohler, H., Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2 (1999), 833–839.
20. Crowder, K.M., Gunther, J.M., Jones, T.A., Hale, B.D., Zhang, H.Z., Peterson, M.R., Scheller, R.H., Chavkin, C., Bajjalieh, S.M., Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 15268–15273.
21. Delahanty, R.J., Kang, J.Q., Brune, C.W., Kistner, E.O., Courchesne, E., Cox, N.J., Cook, E.H. Jr., Macdonald, R.L., Sutcliffe, J.S., Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol. Psychiatry 16 (2011), 86–96.
22. Dibbens, L.M., Feng, H.J., Richards, M.C., Harkin, L.A., Hodgson, B.L., Scott, D., Jenkins, M., Petrou, S., Sutherland, G.R., Scheffer, I.E., Berkovic, S.F., Macdonald, R.L., Mulley, J.C., GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum. Mol. Genet. 13 (2004), 1315–1319.
23. Escayg, A., Goldin, A.L., Sodium channel SCN1A and epilepsy: mutations and mechanisms. Epilepsia 51 (2010), 1650–1658.
24. Evans, M.S., Viola-McCabe, K.E., Caspary, D.M., Faingold, C.L., Loss of synaptic inhibition during repetitive stimulation in genetically epilepsy-prone rats (GEPR). Epilepsy Res. 18 (1994), 97–105.
25. Feng, H.J., Naritoku, D.K., Randall, M.E., Faingold, C.L., Modulation of audiogenically kindled seizures by gamma-aminobutyric acid-related mechanisms in the amygdala. Exp. Neurol. 172 (2001), 477–481.
26. Feng, H.J., Kang, J.Q., Song, L., Dibbens, L., Mulley, J., Macdonald, R.L., Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors. J. Neurosci. 26 (2006), 1499–1506.
27. Goodkin, H.P., Kapur, J., The impact of diazepam's discovery on the treatment and understanding of status epilepticus. Epilepsia 50 (2009), 2011–2018.
28. Guo, D., Zeng, L., Brody, D.L., Wong, M., Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One, 8, 2013, e64078.
29. Hamdan, F.F., Srour, M., Capo-Chichi, J.M., Daoud, H., Nassif, C., Patry, L., Massicotte, C., Ambalavanan, A., Spiegelman, D., Diallo, O., Henrion, E., Dionne-Laporte, A., Fougerat, A., Pshezhetsky, A.V., Venkateswaran, S., Rouleau, G.A., Michaud, J.L., De novo mutations in moderate or severe intellectual disability. PLoS Genet., 10, 2014, e1004772.
30. Han, S., Tai, C., Westenbroek, R.E., Yu, F.H., Cheah, C.S., Potter, G.B., Rubenstein, J.L., Scheuer, T., de la Iglesia, H.O., Catterall, W.A., Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489 (2012), 385–390.
31. Harkin, L.A., Bowser, D.N., Dibbens, L.M., Singh, R., Phillips, F., Wallace, R.H., Richards, M.C., Williams, D.A., Mulley, J.C., Berkovic, S.F., Scheffer, I.E., Petrou, S., Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 70 (2002), 530–536.
32. Hauser, W.A., The prevalence and incidence of convulsive disorders in children. Epilepsia 35:Suppl. 2 (1994), S1–S6.
33. Heron, S.E., Grinton, B.E., Kivity, S., Afawi, Z., Zuberi, S.M., Hughes, J.N., Pridmore, C., Hodgson, B.L., Iona, X., Sadleir, L.G., Pelekanos, J., Herlenius, E., Goldberg-Stern, H., Bassan, H., Haan, E., Korczyn, A.D., Gardner, A.E., Corbett, M.A., Gecz, J., Thomas, P.Q., Mulley, J.C., Berkovic, S.F., Scheffer, I.E., Dibbens, L.M., PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am. J. Hum. Genet. 90 (2012), 152–160.
34. Hoftberger, R., Titulaer, M.J., Sabater, L., Dome, B., Rozsas, A., Hegedus, B., Hoda, M.A., Laszlo, V., Ankersmit, H.J., Harms, L., Boyero, S., de, F.A., Saiz, A., Dalmau, J., Graus, F., Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81 (2013), 1500–1506.
35. Houser, C.R., Do structural changes in GABA neurons give rise to the epileptic state?. Adv. Exp. Med. Biol. 813 (2014), 151–160.
36. Hunt, R.F., Baraban, S.C., Interneuron transplantation as a treatment for epilepsy. Cold Spring Harb. Perspect. Med., 5, 2015.
37. Hunt, R.F., Girskis, K.M., Rubenstein, J.L., Alvarez-Buylla, A., Baraban, S.C., GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat. Neurosci. 16 (2013), 692–697.
38. Ishii, A., Kang, J.Q., Schornak, C.C., Hernandez, C.C., Shen, W., Watkins, J.C., Macdonald, R.L., Hirose, S., A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J. Med. Genet. 54 (2017), 202–211.
39. Ishii, A., Kang, J.Q., Schornak, C.C., Hernandez, C.C., Shen, W., Watkins, J.C., Macdonald, R.L., Hirose, S., A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J. Med. Genet. 54 (2017), 202–211.
40. Isom, L.L., It was the interneuron with the parvalbumin in the hippocampus! no, it was the pyramidal cell with the glutamate in the cortex! searching for clues to the mechanism of dravet syndrome − the plot thickens. Epilepsy Curr. 14 (2014), 350–352.
41. Jallon, P., Latour, P., Epidemiology of idiopathic generalized epilepsies. Epilepsia 46:Suppl. 9 (2005), 10–14.
42. Janve, V.S., Hernandez, C.C., Verdier, K.M., Hu, N., Macdonald, R.L., Epileptic encephalopathy de novo GABRB mutations impair GABAA receptor function. Ann. Neurol., 2016.
43. Janz, R., Goda, Y., Geppert, M., Missler, M., Sudhof, T.C., SV2A and SV2 B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24 (1999), 1003–1016.
44. Johannesen, K., Marini, C., Pfeffer, S., Moller, R.S., Dorn, T., Niturad, C.E., Gardella, E., Weber, Y., Sondergard, M., Hjalgrim, H., Nikanorova, M., Becker, F., Larsen, L.H., Dahl, H.A., Maier, O., Mei, D., Biskup, S., Klein, K.M., Reif, P.S., Rosenow, F., Elias, A.F., Hudson, C., Helbig, K.L., Schubert-Bast, S., Scordo, M.R., Craiu, D., Djemie, T., Hoffman-Zacharska, D., Caglayan, H., Helbig, I., Serratosa, J., Striano, P., De, J.P., Weckhuysen, S., Suls, A., Muru, K., Talvik, I., Talvik, T., Muhle, H., Borggraefe, I., Rost, I., Guerrini, R., Lerche, H., Lemke, J.R., Rubboli, G., Maljevic, S., Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies. Neurology 87 (2016), 1140–1151.
45. Johnston, A.J., Kang, J.Q., Shen, W., Pickrell, W.O., Cushion, T.D., Davies, J.S., Baer, K., Mullins, J.G., Hammond, C.L., Chung, S.K., Thomas, R.H., White, C., Smith, P.E., Macdonald, R.L., Rees, M.I., A Novel GABRG2 mutation p.R136*, in a family with GEFS+ and extended phenotypes. Neurobiol. Dis. 64 (2014), 131–141.
46. Kalume, F., Yu, F.H., Westenbroek, R.E., Scheuer, T., Catterall, W.A., Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J. Neurosci., 27, 2007 1106–1074.
47. Kalume, F., Westenbroek, R.E., Cheah, C.S., Yu, F.H., Oakley, J.C., Scheuer, T., Catterall, W.A., Sudden unexpected death in a mouse model of Dravet syndrome. J. Clin. Invest. 123 (2013), 1798–1808.
48. Kananura, C., Haug, K., Sander, T., Runge, U., Gu, W., Hallmann, K., Rebstock, J., Heils, A., Steinlein, O.K., A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch. Neurol. 59 (2002), 1137–1141.
49. Kang, J.Q., Macdonald, R.L., Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to dravet syndrome. JAMA Neurol. 73:8 (2016), 1009–1016 Aug 1.
50. Kang, J.Q., Shen, W., Macdonald, R.L., The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J. Neurosci. 29 (2009), 2845–2856.
51. Kang, J.Q., Shen, W., Macdonald, R.L., Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype. Ann. Neurol. 74 (2013), 547–559.
52. Kang, J.Q., Shen, W., Zhou, C., Xu, D., Macdonald, R.L., The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration. Nat. Neurosci. 18 (2015), 988–996.
53. Kapur, J., Macdonald, R.L., Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17 (1997), 7532–7540.
54. Karle, J., Woldbye, D.P., Elster, L., Diemer, N.H., Bolwig, T.G., Olsen, R.W., Nielsen, M., Antisense oligonucleotide to GABA(A) receptor gamma2 subunit induces limbic status epilepticus. J. Neurosci. Res. 54 (1998), 863–869.
55. Kash, S.F., Johnson, R.S., Tecott, L.H., Noebels, J.L., Mayfield, R.D., Hanahan, D., Baekkeskov, S., Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 14060–14065.
56. Klassen, T., Davis, C., Goldman, A., Burgess, D., Chen, T., Wheeler, D., McPherson, J., Bourquin, T., Lewis, L., Villasana, D., Morgan, M., Muzny, D., Gibbs, R., Noebels, J., Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 145 (2011), 1036–1048.
57. Kodera, H., Ohba, C., Kato, M., Maeda, T., Araki, K., Tajima, D., Matsuo, M., Hino-Fukuyo, N., Kohashi, K., Ishiyama, A., Takeshita, S., Motoi, H., Kitamura, T., Kikuchi, A., Tsurusaki, Y., Nakashima, M., Miyake, N., Sasaki, M., Kure, S., Haginoya, K., Saitsu, H., Matsumoto, N., De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia 57 (2016), 566–573.
58. Kohling, R., Vreugdenhil, M., Bracci, E., Jefferys, J.G., Ictal epileptiform activity is facilitated by hippocampal GABAA receptor-mediated oscillations. J. Neurosci. 20 (2000), 6820–6829.
59. Krall, R.L., Penry, J.K., Kupferberg, H.J., Swinyard, E.A., Antiepileptic drug development: i: History and a program for progress. Epilepsia 19 (1978), 393–408.
60. Kruer, M.C., Hoeftberger, R., Lim, K.Y., Coryell, J.C., Svoboda, M.D., Woltjer, R.L., Dalmau, J., Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity. JAMA Neurol. 71 (2014), 620–623.
61. Kure, S., Sakata, Y., Miyabayashi, S., Takahashi, K., Shinka, T., Matsubara, Y., Hoshino, H., Narisawa, K., Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy. J. Hum. Genet. 43 (1998), 128–131.
62. Law, C., Schaan, P.M., Levesque, M., Kaltschmidt, J.A., Verhage, M., Kania, A., Normal molecular specification and neurodegenerative disease-Like death of spinal neurons lacking the SNARE-Associated synaptic protein munc18-1. J. Neurosci. 36 (2016), 561–576.
63. Liu, Y., Lopez-Santiago, L.F., Yuan, Y., Jones, J.M., Zhang, H., O'Malley, H.A., Patino, G.A., O'Brien, J.E., Rusconi, R., Gupta, A., Thompson, R.C., Natowicz, M.R., Meisler, M.H., Isom, L.L., Parent, J.M., Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism. Ann. Neurol. 74 (2013), 128–139.
64. Löscher, W., Valproate enhances GABA turnover in the substantia nigra. Brain Res. 501:1 (1989), 198–203 Oct 30.
65. Lubin, F.D., Epileptogenesis: can the science of epigenetics give us answers?. Epilepsy Curr. 12 (2012), 105–110.
66. Ma, Y., Prince, D.A., Functional alterations in GABAergic fast-spiking interneurons in chronically injured epileptogenic neocortex. Neurobiol. Dis. 47 (2012), 102–113.
67. Ma, C., Su, L., Seven, A.B., Xu, Y., Rizo, J., Reconstitution of the vital functions of Munc18 and Munc13 in neurotransmitter release. Science 339 (2013), 421–425.
68. Macdonald, R.L., Kang, J.Q., Gallagher, M.J., Feng, H.J., GABA(A) receptor mutations associated with generalized epilepsies. Adv. Pharmacol. 54 (2006), 147–169.
69. Macdonald, R.L., Kang, J.Q., Gallagher, M.J., Mutations in GABAA receptor subunits associated with genetic epilepsies. J. Physiol. 588 (2010), 1861–1869.
70. Marini, C., Scheffer, I.E., Nabbout, R., Suls, A., De, J.P., Zara, F., Guerrini, R., The genetics of Dravet syndrome. Epilepsia 52:Suppl. 2 (2011), 24–29.
71. Meehan, A.L., Yang, X., Yuan, L.L., Rothman, S.M., Levetiracetam has an activity-dependent effect on inhibitory transmission. Epilepsia 53 (2012), 469–476.
72. Meisler, M.H., Kearney, J.A., Sodium channel mutations in epilepsy and other neurological disorders. J. Clin. Invest. 115 (2005), 2010–2017.
73. Meldrum, B.S., Update on the mechanism of action of antiepileptic drugs. Epilepsia 37:Suppl 6 (1996), S4–11.
74. Merwick, A., O'Brien, M., Delanty, N., Complex single gene disorders and epilepsy. Epilepsia 53:Suppl. 4 (2012), 81–91.
75. Michetti, C., Castroflorio, E., Marchionni, I., Forte, N., Sterlini, B., Binda, F., Fruscione, F., Baldelli, P., Valtorta, F., Zara, F., Corradi, A., Benfenati, F., The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations. Neurobiol. Dis. 99 (2017), 66–83.
76. Moller, R.S., Wuttke, T.V., Helbig, I., Marini, C., Johannesen, K.M., Brilstra, E.H., Vaher, U., Borggraefe, I., Talvik, I., Talvik, T., Kluger, G., Francois, L.L., Lesca, G., de, B.J., Blichfeldt, S., Chatron, N., Holert, N., Jacobs, J., Swinkels, M., Betzler, C., Syrbe, S., Nikanorova, M., Myers, C.T., Larsen, L.H., Vejzovic, S., Pendziwiat, M., von, S.S., Hopkins, S., Dubbs, H., Mang, Y., Mukhin, K., Holthausen, H., van Gassen, K.L., Dahl, H.A., Tommerup, N., Mefford, H.C., Rubboli, G., Guerrini, R., Lemke, J.R., Lerche, H., Muhle, H., Maljevic, S., Mutations in GABRB3: From febrile seizures to epileptic encephalopathies. Neurology 88 (2017), 483–492.
77. Moller, R.S., Wuttke, T.V., Helbig, I., Marini, C., Johannesen, K.M., Brilstra, E.H., Vaher, U., Borggraefe, I., Talvik, I., Talvik, T., Kluger, G., Francois, L.L., Lesca, G., de, B.J., Blichfeldt, S., Chatron, N., Holert, N., Jacobs, J., Swinkels, M., Betzler, C., Syrbe, S., Nikanorova, M., MyersC, T., Larsen, L.H., Vejzovic, S., Pendziwiat, M., von, S.S., Hopkins, S., Dubbs, H., Mang, Y., Mukhin, K., Holthausen, H., van Gassen, K.L., Dahl, H.A., Tommerup, N., Mefford, H.C., Rubboli, G., Guerrini Lemke, R.J.R., Lerche, H., Muhle, H., Maljevic, S., Mutations in GABRB3: From febrile seizures to epileptic encephalopathies. Neurology 88 (2017), 483–492.
78. Oliva, M., Berkovic, S.F., Petrou, S., Sodium channels and the neurobiology of epilepsy. Epilepsia 53 (2012), 1849–1859.
79. Patzke, C., Han, Y., Covy, J., Yi, F., Maxeiner, S., Wernig, M., Sudhof, T.C., Analysis of conditional heterozygous STXBP1 mutations in human neurons. J. Clin. Invest. 125 (2015), 3560–3571.
80. Petroff, O.A., Rothman, D.L., Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin. Mol. Neurobiol. 16 (1998), 97–121.
81. Poulter, M.O., Brown, L.A., Tynan, S., Willick, G., William, R., McIntyre, D.C., Differential expression of alpha1, alpha2, alpha3, and alpha5 GABAA receptor subunits in seizure-prone and seizure-resistant rat models of temporal lobe epilepsy. J. Neurosci. 19 (1999), 4654–4661.
82. Powell, E.M., Interneuron development and epilepsy: early genetic defects cause long-term consequences in seizures and susceptibility. Epilepsy Curr 13 (2013), 172–176.
83. Reid, C.A., Kim, T., Phillips, A.M., Low, J., Berkovic, S.F., Luscher, B., Petrou, S., Multiple molecular mechanisms for a single GABAA mutation in epilepsy. Neurology 80 (2013), 1003–1008.
84. Rekling, J.C., Jahnsen, H., Mosfeldt, L.A., The effect of two lipophilic gamma-aminobutyric acid uptake blockers in CA1 of the rat hippocampal slice. Br. J. Pharmacol. 99 (1990), 103–106.
85. Rogawski, M.A., Loya, C.M., Reddy, K., Zolkowska, D., Lossin, C., Neuroactive steroids for the treatment of status epilepticus. Epilepsia 54:Suppl. 6 (2013), 93–98.
86. Rohena, L., Neidich, J., Truitt, C.M., Gonzalez, K.D., Tang, S., Devinsky, O., Chung, W.K., Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability. Rare Dis., 1, 2013, e26314.
87. Rubinstein, M., Han, S., Tai, C., Westenbroek, R.E., Hunker, A., Scheuer, T., Catterall, W.A., Dissecting the phenotypes of Dravet syndrome by gene deletion. Brain 138 (2015), 2219–2233.
88. Saitsu, H., Kato, M., Mizuguchi, T., Hamada, K., Osaka, H., Tohyama, J., Uruno, K., Kumada, S., Nishiyama, K., Nishimura, A., Okada, I., Yoshimura, Y., Hirai, S., Kumada, T., Hayasaka, K., Fukuda, A., Ogata, K., Matsumoto, N., De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat. Genet. 40 (2008), 782–788.
89. Scharfman, H.E., Brooks-Kayal, A.R., Is plasticity of GABAergic mechanisms relevant to epileptogenesis?. Adv. Exp. Med. Biol. 813 (2014), 133–150.
90. Scheffer, I.E., Grinton, B.E., Heron, S.E., Kivity, S., Afawi, Z., Iona, X., Goldberg-Stern, H., Kinali, M., Andrews, I., Guerrini, R., Marini, C., Sadleir, L.G., Berkovic, S.F., Dibbens, L.M., PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures. Neurology 79 (2012), 2104–2108.
91. Scheffer, I.E., Berkovic, S., Capovilla, G., Connolly, M.B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G.W., Moshe, S.L., Nordli, D.R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y.H., Zuberi, S.M., ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58 (2017), 512–521.
92. Schubert, J., Siekierska, A., Langlois, M., May, P., Huneau, C., Becker, F., Muhle, H., Suls, A., Lemke, J.R., de Kovel, C.G., Thiele, H., Konrad, K., Kawalia, A., Toliat, M.R., Sander, T., Ruschendorf, F., Caliebe, A., Nagel, I., Kohl, B., Kecskes, A., Jacmin, M., Hardies, K., Weckhuysen, S., Riesch, E., Dorn, T., Brilstra, E.H., Baulac, S., Moller, R.S., Hjalgrim, H., Koeleman, B.P., Jurkat-Rott, K., Lehman-Horn, F., Roach, J.C., Glusman, G., Hood, L., Galas, D.J., Martin, B., de Witte, P.A., Biskup, S., De, J.P., Helbig, I., Balling, R., Nurnberg, P., Crawford, A.D., Esguerra, C.V., Weber, Y.G., Lerche, H., Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat. Genet. 46 (2014), 1327–1332.
93. Shen, D., Hernandez, C.C., Shen, W., Hu, N., Poduri, A., Shiedley, B., Rotenberg, A., Datta, A.N., Leiz, S., Patzer, S., Boor, R., Ramsey, K., Goldberg, E., Helbig, I., Ortiz-Gonzalez, X.R., Lemke, J.R., Marsh, E.D., Macdonald, R.L., De novo GABRG2 mutations associated with epileptic encephalopathies. Brain 140 (2017), 49–67.
94. Spampanato, J., Escayg, A., Meisler, M.H., Goldin, A.L., Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21 (2001), 7481–7490.
95. Sperling, M.R., Klein, P., Tsai, J., Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures. Epilepsia 58 (2017), 558–564.
96. Srivastava, S., Cohen, J., Pevsner, J., Aradhya, S., McKnight, D., Butler, E., Johnston, M., Fatemi, A., A novel variant in GABRB2 associated with intellectual disability and epilepsy. Am. J. Med. Genet. A 164A (2014), 2914–2921.
97. Stamberger, H., Nikanorova, M., Willemsen, M.H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., Cantalupo, G., Capovilla, G., Casara, G., Courage, C., Deprez, M., Destree, A., Dilena, R., Erasmus, C.E., Fannemel, M., Fjaer, R., Giordano, L., Helbig, K.L., Heyne, H.O., Klepper, J., Kluger, G.J., Lederer, D., Lodi, M., Maier, O., Merkenschlager, A., Michelberger, N., Minetti, C., Muhle, H., Phalin, J., Ramsey, K., Romeo, A., Schallner, J., Schanze, I., Shinawi, M., Sleegers, K., Sterbova, K., Syrbe, S., Traverso, M., Tzschach, A., Uldall, P., Van, C.R., Verhelst, H., Viri, M., Winter, S., Wolff, M., Zenker, M., Zoccante, L., De, J.P., Helbig, I., Striano, P., Lemke, J.R., Moller, R.S., Weckhuysen, S., STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 86 (2016), 954–962.
98. Sun, H., Zhang, Y., Liang, J., Liu, X., Ma, X., Wu, H., Xu, K., Qin, J., Qi, Y., Wu, X., SCN1A, SCN1B, and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus. J. Hum. Genet. 53 (2008), 769–774.
99. Suzuki, S., Kawakami, K., Nakamura, F., Nishimura, S., Yagi, K., Seino, M., Bromide, in the therapeutic concentration, enhances GABA-activated currents in cultured neurons of rat cerebral cortex. Epilepsy Res. 19 (1994), 89–97.
100. Tanaka, M., Olsen, R.W., Medina, M.T., Schwartz, E., Alonso, M.E., Duron, R.M., Castro-Ortega, R., Martinez-Juarez, I.E., Pascual-Castroviejo, I., Machado-Salas, J., Silva, R., Bailey, J.N., Bai, D., Ochoa, A., Jara-Prado, A., Pineda, G., Macdonald, R.L., Delgado-Escueta, A.V., Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am. J. Hum. Genet. 82 (2008), 1249–1261.
101. Taylor, C.P., Meldrum, B.S., Na+ channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 16 (1995), 309–316.
102. Toonen, R.F., Wierda, K., Sons, M.S., de, W.H., Cornelisse, L.N., Brussaard, A., Plomp, J.J., Verhage, M., Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 18332–18337.
103. Valente, P., Castroflorio, E., Rossi, P., Fadda, M., Sterlini, B., Cervigni, R.I., Prestigio, C., Giovedi, S., Onofri, F., Mura, E., Guarnieri, F.C., Marte, A., Orlando, M., Zara, F., Fassio, A., Valtorta, F., Baldelli, P., Corradi, A., Benfenati, F., PRRT2 is a key component of the Ca(2 +)-Dependent neurotransmitter release machinery. Cell Rep. 15 (2016), 117–131.
104. Wallace, R.H., Marini, C., Petrou, S., Harkin, L.A., Bowser, D.N., Panchal, R.G., Williams, D.A., Sutherland, G.R., Mulley, J.C., Scheffer, I.E., Berkovic, S.F., Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 28 (2001), 49–52.
105. Wang, J., Shen, D., Xia, G., Shen, W., Macdonald, R.L., Xu, D., Kang, J.Q., Differential protein structural disturbances and suppression of assembly partners produced by nonsense GABRG2 epilepsy mutations: implications for disease phenotypic heterogeneity. Sci. Rep., 6, 2016, 35294.
106. Warner, T.A., Shen, W., Huang, X., Liu, Z., Macdonald, R.L., Kang, J.Q., DIfferential molecular and behavioral alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy. Hum. Mol. Genet. 25:15 (2016), 3192–3207 Aug 1.
107. Xia, G., Pourali, P., Warner, T.A., Zhang, C.Q., Macdonald, L., Kang, J.Q., Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+/Q390X) mice associated with epileptic encephalopathy. Epilepsy Res. 123 (2016), 50–54.
108. Yang, S., Chang, R., Yang, H., Zhao, T., Hong, Y., Kong, H.E., Sun, X., Qin, Z., Jin, P., Li, S., Li, X.J., CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease. J. Clin. Invest. 127 (2017), 2719–2724.
109. Yu, F.H., Mantegazza, M., Westenbroek, R.E., Robbins, C.A., Kalume, F., Burton, K.A., Spain, W.J., McKnight, G.S., Scheuer, T., Catterall, W.A., Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9 (2006), 1142–1149.